Insider · CIK 0001182619

CROSS ALEXANDER D

Reports to the SEC for 3 companies · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001182619

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2013-05-15	ATOSATOSSA THERAPEUTICS, INC.P Purchase	Director	PPurchase	+500 sh	$5.49	+$2,744.95	88,866
2013-05-07	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+41.2K sh	—	—	41,243
2013-05-07	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+41.2K sh	—	—	41,243
2007-06-13	ATRXAdhera Therapeutics, Inc.A Award	Director	AAward	+5,500 sh	—	—	28,000
2007-06-13	ATRXAdhera Therapeutics, Inc. · Nastech Pharmaceutical Company Inc Stock OptionsA Award	Director	AAward	+11.5K sh	$11.60	+$133K	38,000
2006-09-27	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2006-06-13	ATRXAdhera Therapeutics, Inc.A Award	Director	AAward	+5,000 sh	—	—	22,500
2006-06-13	ATRXAdhera Therapeutics, Inc. · Nastech Pharmaceutical Company Inc Stock OptionsA Award	Director	AAward	+10K sh	$13.36	+$134K	26,500
2005-07-20	ATRXAdhera Therapeutics, Inc.A Award	Director	AAward	+16.5K sh	—	—	17,500
2005-07-20	ATRXAdhera Therapeutics, Inc. · Nastech Pharmaceutical Company Inc Stock OptionsA Award	Director	AAward	+16.5K sh	$14.72	+$243K	16,500
2005-01-03	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+1,841 sh	—	—	1,841
2004-05-27	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−1,000 sh	$21.00	−$21K	6,001
2004-05-26	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−2,000 sh	$20.00	−$40K	8,001
2004-05-26	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−1,000 sh	$21.00	−$21K	7,001
2004-05-25	LGNDLIGAND PHARMACEUTICALS INCS Sale	Director	SSale	−2,000 sh	$19.00	−$38K	10,001
2004-01-12	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+2,494 sh	$9.21	+$23K	10,751
2004-01-12	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+5,625 sh	$9.80	+$55.1K	16,376
2004-01-12	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+8,118 sh	$5.81	+$47.2K	24,494
2004-01-12	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,118 sh	—	—	0
2004-01-12	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,494 sh	—	—	0
2004-01-12	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,625 sh	—	—	0

Recent filings

Accepted (ET)
Jun 274
ATOSSA GENETICS INC0000904454-13-000742
SEC(opens sec.gov)
May 94
CROSS ALEXANDER D0000904454-13-000519
SEC(opens sec.gov)
Jun 154
NASTECH PHARMACEUTICAL CO INC0001209191-07-037362
SEC(opens sec.gov)
Sep 284
LIGAND PHARMACEUTICALS INC0000886163-06-000091
SEC(opens sec.gov)
Jun 154
CROSS ALEXANDER D0001209191-06-036748
SEC(opens sec.gov)
Jul 224
CROSS ALEXANDER D0001209191-05-038247
SEC(opens sec.gov)
Jan 54
CROSS ALEXANDER D0001247741-05-000008
SEC(opens sec.gov)
May 274
LIGAND PHARMACEUTICALS INC0001247741-04-000037
SEC(opens sec.gov)
May 264
LIGAND PHARMACEUTICALS INC0001247741-04-000034
SEC(opens sec.gov)
Jan 144
LIGAND PHARMACEUTICALS INC0001247741-04-000018
SEC(opens sec.gov)

Companies

Address

4105 E. MADISON STREET, SUITE 320

SEATTLE, WA, 98112